產品詳情
簡單介紹：
Anti-Phospho-Caspase-9 (Thr125)抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Phospho-Caspase-9 (Thr125)抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Phospho-Caspase-9 (Thr125)
Cat. Number:
Anti-Phospho-Caspase-9 (Thr125)抗體KL-3082R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolyticAnti-Phospho-Caspase-9 (Thr125)抗體 processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Also known as:
APAF 3; APAF3; ApoptosisAnti-Phospho-Caspase-9 (Thr125)抗體 related cysteine peptidase; Apoptotic protease activating factor 3; Apoptotic protease Mch 6; CASP 9; CASP9; Caspase 9 Dominant Negative; Caspase 9 precursor; Caspase 9c; Caspase9; EC 3.4.22.; ICE LAP6; ICE like apoptotic protease 6; MCH6 antibody RNCASP9; CASP9_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .Anti-Phospho-Caspase-9 (Thr125)抗體
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Caspase-9 around the phosphorylation site of Thr125.
●
Predicted Molecular Weight: 35kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-Phospho-Caspase-9 (Thr125)抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 Anti-Phospho-Caspase-9 (Thr125)抗體 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl141Mu02 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl142Mu02 細胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl144Mu02 血管內皮生長因子B(VEGFB)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl145Mu02 血管內皮生長因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl146Mu02 血管內皮生長因子D(VEGFD)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl147Mu02 脂聯素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl149Mu02 Ⅳ型膠原α1(COL4α1)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl151Mu02 激肽釋放酶3(KLK3)多克隆抗體 Polyclonal Antibody to Kallikrein 3 (KLK3)
kl153Mu02 甲胎蛋白(αFP)多克隆抗體 Polyclonal Antibody to Alpha-Fetoprotein (aFP)
kl154Mu02 糖抗原125(CA125)多克隆抗體 Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)
kl159Hu02 鱗狀細胞癌抗原2(SCCA2)多克隆抗體 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)
kl159Mu02 鱗狀細胞癌抗原2(SCCA2)多克隆抗體 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)
